Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
Sarah Kristine Nørgaard, Jens Nielsen, Anne Christine Nordholm, Lukas Richter, Alena Chalupka, Natalia Bustos Sierra, Toon Braeye, María Athanasiadou, Theodore Lytras, Gleb Denissov, Oskari Luomala, Anne Fouillet, Isabelle Pontais, Matthias an der Heiden, Benedikt Zacher, Alina Weigel, Ivo Foppa, Kassiani Gkolfinopoulou, Ioannis Panagoulias, Anna Páldy, Tibor Malnasi, Lisa Domegan, E. Lowell Kelly, Naama Rotem, Oksana Rakhlin, Francesca de’Donato, Chiara Di Blasi, P. Hoffmann, Telma Velez, Kathleen England, Neville Calleja, Liselotte van Asten, Femke Jongenotter, Ana Paula Rodrigues, Susana Pereira Silva, Petra Klepac, Diana Gómez‐Barroso, Inmaculada León-Gómez, Ilias Galanis, Farah Ahmed, Rolf Weitkunat, Katarina Fehst, Nick Andrews, Tom Clare, Declan Bradley, Mark G. O’Doherty, Naoma William, Mark Hamilton, Bolette Søborg, Tyra Grove Krause, Nick Bundle, Lasse S Vestergaard
Abstract
Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023-6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7-98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.